drugset / Trial / NCT01827592
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
RandomizedParallel-groupDouble-blindTreatment
Summary
Efficacy and Safety Trial of elobixibat in Patients with Chronic Idiopathic Constipation treated for 26 Weeks.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-03
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elobixibat | Small molecule | 5 mg | — |
| Subject | Elobixibat | Small molecule | 10 mg | — |